
Pulmonx Corporation: updates and filings
Price
$2.69
November 18, 2026Market cap $114M
What Ploutos Investor adds for Pulmonx
Part of Ploutos Investor, €9.99 a month
- The full history: 8 fiscal years, from 2018
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Oct 27, 2026next Jan 29, 2027
An estimate from when it has reported before, and the timing has varied a little. The company announces the date itself.
October 2026
March 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 5, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 3, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Oct 27, 2026Results of operationsForm8-K
- Aug 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 4, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jul 29, 2026Results of operationsForm8-K
- Jul 29, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jun 4, 2026Shareholder voteForm8-K
- May 19, 2026Conflict minerals reportFormSD
- May 4, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- Apr 29, 2026Results of operationsForm8-K
- Apr 22, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 22, 2026Additional annual meeting materialFormDEFA14A
- Apr 22, 2026Annual meeting proxy statementFormDEF 14A
- Mar 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 10, 2026Shares registered for employeesFormS-8
- Mar 10, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Mar 9, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Mar 5, 2026Material agreement entered, material agreement ended, new material financial obligation, unregistered sale of sharesForm8-K
- Mar 4, 2026Results of operationsForm8-K
- Nov 25, 2025FilingFormEFFECT
- Nov 24, 2025Correspondence with the SECFormCORRESP
- Nov 24, 2025Shelf registration for future offerings (amendment)FormS-3/A
- Nov 24, 2025Shares registered for employeesFormS-8
- Nov 18, 2025Letter from the SECFormUPLOAD
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 5, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 3, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Oct 27, 2026 | 8-K | Results of operations | Document |
| Aug 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 4, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jul 29, 2026 | 8-K | Results of operations | Document |
| Jul 29, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jun 4, 2026 | 8-K | Shareholder vote | Document |
| May 19, 2026 | SD | Conflict minerals report | Document |
| May 4, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| Apr 29, 2026 | 8-K | Results of operations | Document |
| Apr 22, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 22, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 22, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 10, 2026 | S-8 | Shares registered for employees | Document |
| Mar 10, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Mar 9, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Mar 5, 2026 | 8-K | Material agreement entered, material agreement ended, new material financial obligation, unregistered sale of shares | Document |
| Mar 4, 2026 | 8-K | Results of operations | Document |
| Nov 25, 2025 | EFFECT | Filing | Document |
| Nov 24, 2025 | CORRESP | Correspondence with the SEC | Document |
| Nov 24, 2025 | S-3/A | Shelf registration for future offerings (amendment) | Document |
| Nov 24, 2025 | S-8 | Shares registered for employees | Document |
| Nov 18, 2025 | UPLOAD | Letter from the SEC | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Dec 9, 2003.
The full analysis
What do Pulmonx's filings show?
The filings are where every one of Pulmonx's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.